Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Washington Research Foundation awards $10M to Seattle Hub for Synthetic Biology to advance cell and genome technologies


News provided by

Washington Research Foundation

Mar 06, 2025, 11:03 ET

Share this article

Share toX

Share this article

Share toX

Washington Research Foundation
Washington Research Foundation

Five-year grant, one of the largest in the foundation's history, will support groundbreaking work by UW Medicine's Brotman Baty Institute and the Allen Institute

SEATTLE, March 6, 2025 /PRNewswire-PRWeb/ -- Washington Research Foundation (WRF) has pledged $10 million over five years in support of a new program led by UW Medicine's Brotman Baty Institute (BBI) and the Allen Institute. The program, SeaBridge, will advance cell and genome reprogramming technologies developed at the Seattle Hub for Synthetic Biology (Seattle Hub) to help address a wide range of diseases. The grant is among the largest in WRF's 44-year history.

Seattle Hub is a collaboration among BBI, the Allen Institute, and the Chan Zuckerberg Initiative (CZI). Dr. Jay Shendure, BBI Scientific Director, leads Seattle Hub. He also holds faculty positions at the University of Washington School of Medicine and is a Howard Hughes Medical Institute investigator.

"This is beyond exciting. Large-scale grant partnerships can really help to accelerate critical life science initiatives in our region. SeaBridge is a great example of this." Dr. Tom Daniel, president and CEO of WRF

Post this

Building on core technologies developed at BBI, Seattle Hub opened in January 2024 to generate foundational datasets, models and molecular infrastructure to re-engineer cells to record their own histories and reprogram disease states into healthy functions. The Allen Institute and the CZI each committed $35 million in 2023 to establish Seattle Hub.

The purpose of the SeaBridge grant is to train a new generation of scientists, leverage the region's expertise in cell therapy, and launch startups to drive clinical applications that will improve health through advanced treatment options for diseases that include cancers, as well as neurological and immune disorders.

The SeaBridge program will recruit and train 40 postdoctoral fellows to further advance Seattle Hub's technologies, which include the DNA Typewriter and ENGRAM created in Shendure's UW Medicine lab. In addition to Shendure, the SeaBridge program will also be led by Seattle Hub Co-Director Dr. Marion Pepper, Chair of the UW Medicine Department of Immunology, and Dr. Jesse Gray, Seattle Hub Senior Director, Strategy and Platform, at the Allen Institute.

"This generous WRF grant enables Seattle Hub to establish a new postdoctoral fellowship training program, a program that will move Seattle forward as the epicenter of synthetic biology," said Pepper.

The fellowship program will be administrated by BBI. Fellows will carry out their work at UW Medicine and other academic research institutions in the state. The hope is that researchers will advance several technologies to the point where new companies can be created locally to commercialize novel therapeutics, diagnostics or other cell-based technologies that address a variety of clinical conditions and diseases.

"Our vision is these new companies will bridge Seattle's rich synthetic biology ecosystem and our enterprising fellows to create companies armed with new clinical interventions to improve patients' lives," said Gray.

Seattle Hub received a $105,000 planning grant from WRF last year to develop a detailed plan for the SeaBridge program.

WRF made the $10M award through its new BioInnovation Grant program, President and CEO Dr. Tom Daniel said, which the foundation launched in response to a key goal of its 2023 strategic plan: increasing support for big, emergent opportunities to advance Washington state's life sciences ecosystem and improve lives.

"This is beyond exciting," Daniel said. "Large-scale grant partnerships can really help to accelerate critical life science initiatives in our region. SeaBridge is a great example of this."

Additional support for the SeaBridge program includes commitments from BBI, CZI, the Allen Institute, UW Medicine, and the fellows' host institutions.

Dr. Meher Antia, Director of Grant Programs at WRF, said, "WRF is delighted to support the SeaBridge program through our first BioInnovation Grant. SeaBridge fulfils many of the goals of the BioInnovation Grant program in translating a novel and exciting platform technology into concrete applications in a way that builds on the region's strengths. The matching funds from CZI, BBI, UW Medicine and the Allen Institute make this a genuine partnership between WRF, the research institutions and other funders, which is also a key feature of the BioInnovation Grants."

About Washington Research Foundation:

Washington Research Foundation (WRF) supports research and scholarship in Washington state, with a focus on life sciences and enabling technologies.

WRF was founded in 1981 to assist universities and other nonprofit research institutions in Washington with the commercialization and licensing of their technologies. WRF is one of the foremost technology transfer and grant-making organizations in the nation, having earned more than $445 million in licensing revenue for the University of Washington and providing over $170 million in grants to the state's research institutions to date.

WRF Capital, the investment vehicle for Washington Research Foundation, has backed 132 local startups since 1996. Returns support the foundation's investment and grantmaking programs.

For additional information, please visit wrfseattle.org.

About the Brotman Baty Institute:

The Brotman Baty Institute leverages of Seattle's culture of collaboration in genomics, bioinformatics, and data science through private and public funding. It builds on its successes in long-read and RNA sequencing, single cell profiling, and genomic variation analyses, among other areas of research with potential clinical applications.

Since it was established in 2017 with philanthropic support from Jeff and Susan Brotman and Dan and Pam Baty, BBI has been recognized for its work at the intersection of technology and health in the Puget Sound region and beyond. Its scientists and researchers at UW Medicine, the Fred Hutchinson Cancer Center, and Seattle Children's have broken barriers across organizational lines.

Learn more at Brotmanbaty.org

Media Contact

Dale Wadman, Washington Research Foundation, (206) 336-5600, [email protected], https://www.wrfseattle.org/ 

SOURCE Washington Research Foundation

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.